01
Clinical Monitoring
Full-cycle site monitoring — from feasibility assessments and site initiation through interim visits and close-out — with rigorous source document verification and query resolution.
MzansiClinica Pty Ltd is a South African clinical research and quality assurance consultancy dedicated to helping sponsors, CROs, and clinical research sites achieve regulatory compliance and inspection-ready excellence across Sub-Saharan Africa.
Founded on nearly two decades of hands-on clinical trial and quality leadership experience, MzansiClinica bridges the gap between global Good Clinical Practice (GCP) standards and the practical realities of running trials across the African regulatory landscape.
Our team has supported clinical research spanning Phase I first-in-human studies through pivotal Phase IIIb efficacy trials, across therapeutic areas including HIV/AIDS prevention, tuberculosis, oncology, COVID-19, and women's and children's health.
MzansiClinica (Pty) Ltd has established long-term contractual relationships with external study sponsors and research organisations supporting clinical research activities across Africa.
These ongoing engagements demonstrate MzansiClinica's ability to establish and maintain long-term professional relationships with research organisations, provide independent external site management support, and operate effectively within the African clinical research environment across early-phase clinical development programmes.
Where required and subject to client confidentiality obligations, MzansiClinica can provide appropriate supporting documentation or references to substantiate its experience and contractual relationships.
Full-cycle site monitoring — from feasibility assessments and site initiation through interim visits and close-out — with rigorous source document verification and query resolution.
End-to-end management of SAHPRA and ethics committee (IRB/IEC) submissions, including protocol amendments, safety reporting, and study close-outs.
Design and implementation of QMS frameworks aligned with ICH E6(R2), including SOP development, risk-based monitoring, and CAPA lifecycle management.
Mock audits, documentation reviews, and staff preparedness coaching to help sites and sponsors achieve consistently successful regulatory inspection outcomes.
GCP training and mentoring for trial-naïve site staff, coordinators, and CRAs, building sustainable in-country research capacity.
Responsible innovation focused on strengthening how clinical studies are planned, conducted, documented and managed across Africa — while keeping participant safety, rights, data integrity and scientific quality at the centre.
MzansiClinica (Pty) Ltd is committed to contributing to the continuous improvement of clinical research practices and the way clinical studies are planned, conducted, documented and managed across Africa.
The organisation seeks to identify practical opportunities to improve research processes, site performance, participant experience, data quality, oversight and operational efficiency, while ensuring that such improvements do not compromise or infringe applicable ICH GCP, South African GCP, regulatory, ethical or institutional requirements.
MzansiClinica's approach is based on responsible innovation within the existing regulatory and ethical framework, with patient safety, participant rights, data integrity and scientific quality remaining central to all proposed improvements.
As part of this commitment, MzansiClinica actively participates in the development of grant proposals and research concepts focused on improving clinical research capacity, systems and processes in Africa. This includes identifying relevant funding opportunities and developing proposals that may support:
MzansiClinica views innovation as complementary to, rather than a replacement for, established clinical research standards. All proposed innovations are intended to operate within the requirements of ICH GCP, South African GCP, applicable regulatory requirements and research ethics principles.
Through its operational experience, external site management activities, clinical research partnerships and involvement in grant development, MzansiClinica seeks to contribute not only to the successful delivery of individual studies, but also to the long-term strengthening and modernisation of clinical research in Africa.
At MzansiClinica, we believe robust research quality isn't just about passing an inspection — it's about embedding a genuine culture of compliance and scientific integrity into every site we work with.
We serve as a trusted partner and communication hub between sponsors, CROs, vendors, and investigational sites, proactively resolving issues before they become risks.
We combine local context, human judgement and disciplined clinical research processes to protect participants, preserve data integrity and improve operational performance.
Understand the study, site environment, stakeholders and critical quality factors.
Review processes, documentation, facilities and operational risks.
Implement practical CAPAs, training, SOP improvements and targeted interventions.
Measure effectiveness and build capability so quality remains embedded.
Support from feasibility through closeout, with emphasis on participant protection, protocol compliance and data integrity.
Review, adapt or establish quality systems appropriate to site maturity and study requirements.
Compilation and submission support for local IRB/IEC and regulatory documentation.
Tailored training for research teams and clinical-trial-naïve sites, including inspection readiness.
We welcome strategic relationships with sponsors, global and regional CROs, biotechnology companies, medical-device organisations, academic institutions, investigators and clinical research sites.
Extend your operational reach with an Africa-based partner that understands local site realities, quality and execution.
Explore a partnership →Strengthen your site with QMS support, SOPs, training, compliance assessments and inspection-readiness coaching.
Become a partner →Client testimonials will be featured here as approved by our partners, highlighting measurable improvements in quality, site readiness and clinical research execution.
Our focus is to help research teams create processes that protect participants, preserve data integrity and remain effective under scrutiny.
Tell us where you are in the research journey and what needs to move forward.
For clinical research support, partnership opportunities or general enquiries, reach out directly.
For enquiries and business correspondence
+27 78 552 1081 →